AnalystsDev PrasadDev Prasad's Stock Forecasts
AnalystsDev Prasad
Sectors:
Industries:
Analyst Ranking
Top 30%
#1646 out of 5550 analysts
Average Return
+28.48%
Win Rate
27%3 out of 11
Risk vs Reward
Poor
Good
Dev Prasad's 5 best and worst ratings
Dev Prasad Analyst Color
Get additional color on Dev Prasad's coverage of popular stocks
Dev Prasad's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Turn Therapeutics IncTTRX | 1 | Strong Buy | $24.00 | +130.11% | Initiates Coverage On | a month ago |
Faeth Therapeutics IncFTH | 1 | Strong Buy | $59.00 | +215.68% | Initiates Coverage On | 2 months ago |
Adlai Nortye Group LtdANL | 1 | Strong Buy | $49.00 | +413.09% | Assumes | 2 months ago |
Eloxx Pharmaceuticals IncELOX | 1 | Strong Buy | $38.00 | +182.53% | Initiates Coverage On | 2 months ago |
Polaryx Therapeutics IncPLYX | 1 | Strong Buy | $7.00 | +300.00% | Initiates Coverage On | 3 months ago |
Quoin Pharmaceuticals LtdQNRX | 1 | Strong Buy | $30.00 | +560.79% | Initiates Coverage On | 6 months ago |
Atyr Pharma IncATYR | 1 | Hold | $40.00 | N/A | Downgrades | a year ago |
Cue Biopharma IncCUE | 1 | Strong Buy | $120.00 | N/A | Initiates Coverage On | a year ago |
Opus Genetics IncIRD | 1 | Strong Buy | $5.00 | N/A | Initiates Coverage On | a year ago |
Avalo Therapeutics IncAVTX | 1 | Strong Buy | $24.00 | N/A | Initiates Coverage On | 2 years ago |
Ibio IncIBIO | 1 | Strong Buy | $6.00 | N/A | Initiates Coverage On | 2 years ago |
Calcimedica IncCALC | 1 | Strong Buy | $65.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.